Eli Lilly and Co to supply 650,000 more doses of COVID-19 drug to U.S. government

The new purchase is part of a U.S. government deal to secure nearly 1 million doses of Lilly's bamlanivimab, a treatment similar to Regeneron Pharmaceuticals Inc's COVID-19 antibody therapy that U.S. President Donald Trump received in October during his illness.

from News-Economic Times https://ift.tt/3ookPVD